Vrije Universiteit Amsterdam
Amsterdam, North Holland, 1081HV, Netherlands
Location status: Recruiting
NCT Number: NCT06539078
Healthy ageing is associated with the loss of muscle mass and physical function. As a result, older people are limited in their independence. The aging of muscles typically begins around the age of 30. From this age onward, muscle strength, muscle mass, and the maximum oxygen uptake of muscles decrease. The reasons for this are not entirely clear, but it seems to be partly related to how oxygen moves from our blood vessels to the muscles and how muscles burn energy. The precise role of age and physical fitness, as well as whether exercise can counteract the effects of ageing, is still unknown. Therefore, in this study, we aim to investigate the muscle function of both physically active and inactive young and middle-aged individuals. We hypothesise that endurance training can mitigate some of the effects of ageing.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Amsterdam, North Holland, 1081HV, Netherlands
Location status: Recruiting
Healthy ageing is associated with a loss of muscle mass and physical function. This loss of physical function is underpinned by reductions in characteristics such as muscle strength, power, and maximal oxygen uptake (V̇O2max; reflecting exercise capacity). However, the causal contributors to these age-associated impairments, and the role of exercise training status in mitigating them, remain poorly defined. Skeletal muscle mitochondrial function has been proposed to be a key contributor to age-associated effects on physical function, however many conflicting results are present in the extant human literature. Moreover, diffusion of oxygen from capillaries to mitochondria is a key determinant of V̇O2max, however, whether the skeletal muscle diffusive capacity for oxygen (DmO2) declines with age is unknown. A new technique utilizing near-infrared spectroscopy (NIRS) will enable the non-invasive assessment of skeletal muscle diffusive capacity in young and elderly subjects for the first time to resolve this issue. The primary aims of this study are therefore to 1) compare DmO2 derived via NIRS between young sedentary, young endurance-trained, older sedentary, and older endurance-trained subjects; 2) to compare non-invasive (i.e. with NIRS and 31phosphorous magnetic resonance spectroscopy [31P-MRS]) and invasive (i.e. measures of mitochondrial morphology and respiration obtained by skeletal muscle biopsy) markers of mitochondrial function between the same groups, and 3) to assess the relationships between DmO2, mitochondrial measures and assessments of capillarization with functional measurements of muscle strength, power, and V̇O2max.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In order to be eligible to participate in this study, young sedentary participants must meet all of the following criteria:
In order to be eligible to participate in this study, young trained participants must meet all of the following criteria:
In order to be eligible to participate in this study, older sedentary participants must meet all of the following criteria:
In order to be eligible to participate in this study, older trained participants must meet all of the following criteria:
Exclusion criteria
Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.
Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.
To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.
Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.
Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy [31P-MRS].
A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.
Time frame: Baseline (visit 1)
ml/min/kg
Time frame: Baseline (visit 1)
cm^3
Time frame: Baseline (visit 1)
Newton-metre (Nm)
Time frame: Baseline (visit 1)
Watt (W)
Time frame: Baseline (visit 1) and visit 2-4. In total 4 weeks.
Differences in recovery constant k (min-1) obtained under conditions of high, medium or low O2 availability
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks).
Degree of fragmentation of the mitochondrial pool.
Time frame: Baseline (visit 1)
L/min
Time frame: Baseline (visit 1)
Watt (W)
Time frame: Baseline (visit 1)
sec
Time frame: Baseline (visit 1) and during visit 2-4 (max 4 weeks in total)
beats per minute (bpm)
Time frame: Baseline (visit 1)
ml/beat
Time frame: Baseline (visit 1)
V̇E/V̇CO2 slope
Time frame: Baseline (visit 1)
beats/L/min
Time frame: Baseline (visit 1)
RER = VCO2/VO2
Time frame: Baseline (visit 1)
VE/VCO2 and VE/VO2
Time frame: Baseline (visit 1)
mmHg
Time frame: Baseline (visit 1)
mmol/L
Time frame: Baseline (visit 1)
breaths/min
Time frame: Baseline (visit 1) and visit 2-4 (max 4 weeks in total)
L/min
Time frame: Visit 2-4 (max 4 weeks in total)
sec
Time frame: Visit 2-4 (max 4 weeks in total)
L/min
Time frame: Baseline (visit 1) and visit 2-4 (max 4 weeks in total)
HbO2 and Hbb: % maximal value, TSI (%) = HbO2/(HbO2+Hbb) For all variables resting concentration, baseline cycling concentration, (sub)maximal exercise concentration will be reported.
Time frame: Baseline (visit 1)
HbO2 and Hbb: % maximal value, TSI (%) = HbO2/(HbO2+Hbb) versus relative (%max) and absolute power output (W) Relative and absolute work rates comparisons will be reported for all variables: resting concentration, baseline cycling concentration, (sub)maximal exercise concentration.
Time frame: Baseline (visit 1)
concentration[Hbb/HbO2/TSI]%/delta%peak power(W)
Time frame: Baseline (visit 1)
concentration[Hbb/HbO2/TSI]%/deltaW
Time frame: Baseline (visit 1)
Power output (W) and maximal oxygen uptake (L/min)
Time frame: Baseline (visit 1)
sec
Time frame: Baseline (visit 1)
cm
Time frame: Baseline (visit 1)
degrees
Time frame: Baseline (visit 1)
cm2
Time frame: Baseline (visit 1)
N/cm2
Time frame: Baseline (visit 1)
PCSA/muscle fiber cross-sectional area
Time frame: Baseline (visit 1)
mm
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks).
pmol/s/mg
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks).
OXPHOS/ETS, LEAK/ETS, LEAK/OXPHOS, LEAK/NADH-linked, ROT+S/ETS, (OXPHOS-LEAK)/ETS, (OXPHOS-LEAK)/OXPHOS, (ETS-LEAK)/ETS, (ETS-OXPHOS)/ETS
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks).
(pmol/s/mg)/mitochondrial area density (%) For: background, LEAK, N-linked respiration, OXPHOS, ETS, succinate + rotenone-linked uncoupled respiration
Time frame: Visit 5 MRI
mM pH = unitless
Time frame: Visit 5 MRI
Rate constant of Phosphocreatine [PCr] on- and off-kinetics (sec)
Time frame: Visit 5 MRI
mM/s
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
Type I, IIa, IIx and hybrid fiber-type proportions (%)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
um
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
um2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
A660/um/s
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
A660.um/s
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
mM
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
number of capillaries/mm2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
capillary-to-fiber ratio
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
number of capillaries
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
number of capillaries/um2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
CFPE (unitless)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
percentage (%)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - staining within time window of 2 years.
um
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - western blot within time window of 2 years.
ug/mg loaded sample
Time frame: Baseline 7 days
Number of steps per day
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - electron microscopy (EM) within time window of 2 years.
Percentage (%)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
um3.um3.10^2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
number/um2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
um2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
um
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
um/um^2
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
Circularity (AU)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
Roundness (AU)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
Aspect ratio (AU)
Time frame: Visit 6 muscle biopsy (+/- after 4 weeks) - EM within time window of 2 years.
Percentage (%)
Contact information is provided by the study sponsor or research team.
VU University of Amsterdam
Other
Exercise as a Countermeasure Against the Effects of Ageing on Muscle Mitochondria, Diffusive Oxygen Transport and Muscle Volume
Acronym: AGAMEMNON
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07593677
Aging, Behavior
Ann Arbor, Michigan, United States
View Trial DetailsNCT06107842
Aging, Behavior
West Los Angeles, California, United States
View Trial DetailsNCT07621523
Aging, Behavior
Jacarezinho, Paraná, Brazil
View Trial DetailsNCT06692543
Aging, Behavior
Nice, France
View Trial Details